C/ebp-family redundancy determines patient survival and lymph node involvement in pdac

HIGHLIGHTS

  • who: Leonie Hartl and collaborators from the Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, AZ Amsterdam, The Netherlands have published the paper: C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC, in the Journal: (JOURNAL) of 10/Nov/2022
  • what: The authors assessed whether the quantification of C/EBPu03b2 or C/EBPu03b3 in addition to that of C/EBPu03b4 might improve the prediction of patient and involvement using a cohort of 68 resectable patients. The aim of this study was . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?